ArticleBMC cancer2026
SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity.
Li Hongmin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleBMC cancer2026
Li Hongmin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.